Android
iOS
Windows| LClose | 6.70 | Price | 6.70 |
|---|---|---|---|
| Change | 0.00 (0.00%) | Low | 6.70 |
| High | 6.70 | EPS | 0.58 |
| 52WkHigh | 8.70 | 52WkLow | 3.45 |
| 50d Mov Avg | 6.93 | 200d Mov Avg | 6.30 |
| AvgDlyVol | 940.14K | 3MthChg | 0.10 (1.52%) |
| 6MthChg | 1.70 (34.00%) | 12MthChg | 3.25 (94.20%) |
| Beta | 0.7032763 | Risk Factor | 0.05068199 |
| PE | 11.57 | Shares Outs. | 1.20B |
| Div. Yield | 8.21 | Market Cap | 8.01B |
| Volume | 51.00K | # Of Trades | 9 |
| Trades Value | 339.10K | ||
| Sector | Pharmaceuticals | ||
Statement of Comprehensive Income as at
31-Mar-2018
| Name | Amount |
|---|---|
| Revenue | 18,411,475.00 |
| Profit before taxation | 1,160,154.00 |
| Taxation (expense)/credit | -542,530.00 |
| Profit after tax | 617,624.00 |
| Transfer to revenue reserve | 617,624.00 |
| Profit attributable to: | |
| Owners of the company | 617,624.00 |
| Non-controlling interest | |
| Earnings per 50k share (k) | 52.00 |
| Net assets per 50k share (k) | 7.00 |
| Name | Title |
|---|---|
| Edmund Onuzo | Chairman of the Board |
| Jonathan Murray | Finance Director, Director |
| Seyi Adesomi | Head of Operations |
| Henry Akpoguma | Head of IT |
| Ayodeji Owadara | Manager, Compliance |
| Uchenna Uwechia | Head of Legal/Company Secretary |
| Dayanand Sriram | Managing Director, Director |
| T. Dayanand | General Manager, GSK Cx |
| Raphael Adebiyi | Finance Controller |
| Kayode Adebiyi | Sales Director |
| Kerry Alexander | Marketing Director |
| Adediran Aderemi | Head of Human Resources |